ABL Diagnostics cuts cash allocation to liquidity contract by EUR 50,000
ABL Diagnostics cut cash allocated to its liquidity contract with Invest Securities by EUR 50,000 on Sept. 18, 2026. Post-adjustment resources stood at 27,852 shares, EUR 43,873.58 in cash at the market close. At the June 30, 2026 semiannual review, the liquidity account held 33,993 shares, EUR 76,654.75 in cash. Discl